Related Experiment Video
Updated: Jul 11, 2025
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Biomimetic nanomedicines for precise atherosclerosis theranostics
Ying Tao1, Xinmiao Lan2, Yang Zhang3
1Department of Minimally Invasive Interventional Radiology, Key Laboratory of Molecular Target & Clinical Pharmacology, School of Biomedical Engineering & the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.
Biomimetic nanomedicines offer promising biocompatible solutions for diagnosing and treating atherosclerosis (AS), a major cause of cardiovascular disease (CVD). This review explores their development and potential for atherosclerotic theranostics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cardiovascular Medicine
Background:
- Atherosclerosis (AS) is a primary driver of cardiovascular disease (CVD), necessitating advanced diagnostic and therapeutic strategies.
- Current treatments face limitations, highlighting the need for innovative, biocompatible approaches.
Purpose of the Study:
- To review the diagnostic and therapeutic applications of biomimetic nanomedicines (bNMs) for atherosclerosis.
- To trace the developmental progress and future trajectory of bNMs in atherosclerotic theranostics.
Main Methods:
- Literature review of nanomedicine research focused on atherosclerosis.
- Analysis of biomimetic strategies in nanocarrier design.
- Synthesis of current advancements and future prospects in theranostic nanomedicine.
Main Results:
- Biomimetic nanomedicines demonstrate potential for targeted delivery and enhanced efficacy in AS treatment.
- bNMs offer theranostic capabilities, integrating diagnosis and therapy.
- Significant progress has been made in designing biocompatible nanocarriers for AS.
Conclusions:
- Biomimetic nanomedicines represent a promising frontier for managing atherosclerosis.
- Further research and development are crucial for clinical translation of atherosclerotic theranostics.
- bNMs are poised to advance the field of cardiovascular nanomedicine.
